Grufity logo
Grufity logo

Latest ARMISTICE CAPITAL, LLC Stock Portfolio

$5.62Billion | No. of Holdings #251

ARMISTICE CAPITAL, LLC Performance

2026 Q1-7.34%
YTD-7.34%
2025+10.43%

About ARMISTICE CAPITAL, LLC and 13F Hedge Fund Stock Holdings

ARMISTICE CAPITAL, LLC is a hedge fund based in New York, NY. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, ARMISTICE CAPITAL, LLC reported an equity portfolio of $5.6 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of ARMISTICE CAPITAL, LLC are TVTX, PTCT, MDGL. The fund has invested 2.6% of it's portfolio in TRAVERE THERAPEUTICS INC and 2.5% of portfolio in PTC THERAPEUTICS INC. <br><br> The fund managers got completely rid off ARGENX SE (ARGX), STARBUCKS CORP (SBUX) and MEDTRONIC PLC (MDT) stocks. They significantly reduced their stock positions in KENVUE INC, ZETA GLOBAL HOLDINGS CORP (ZETA) and PDS BIOTECHNOLOGY CORP (PDSB). ARMISTICE CAPITAL, LLC opened new stock positions in UNITEDHEALTH GROUP INC (UNH), META PLATFORMS INC (META) and CENTRAL GARDEN & PET CO (CENT). The fund showed a lot of confidence in some stocks as they added substantially to CORNING INC (GLW), BLOOM ENERGY CORP (BE) and MEDLINE INC.
ARMISTICE CAPITAL, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$5.62Billion
  as of May 15, 2026

ARMISTICE CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ARMISTICE CAPITAL, LLC made a return of -7.34% in the last quarter. In trailing 12 months, it's portfolio return was 12.85%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
unitedhealth group inc40,047,300
meta platforms inc18,648,000
central garden & pet co15,496,800
capri holdings limited11,594,000
xeris biopharma holdings inc11,077,100
esperion therapeutics inc ne10,768,500
iqvia hldgs inc10,383,200
sangamo therapeutics inc9,974,780
New stocks bought by ARMISTICE CAPITAL, LLC

Additions

Ticker% Inc.
corning inc1,127
bloom energy corp987
medline inc873
comfort sys usa inc652
sandisk corp486
harmony biosciences hldgs in224
roblox corp154
toast inc153
Additions to existing portfolio by ARMISTICE CAPITAL, LLC

Reductions

Ticker% Reduced
kenvue inc-99.26
zeta global holdings corp-97.43
pds biotechnology corp-93.88
e l f beauty inc-91.58
ge healthcare technologies i-85.06
agree rlty corp-78.41
gsk plc-76.4
worksport ltd-74.1
ARMISTICE CAPITAL, LLC reduced stake in above stock

Sold off

Ticker$ Sold
akari therapeutics plc-787,226
adial pharmaceuticals inc-561,977
gold royalty corp-4,356,000
medicus pharma ltd-2,770,770
mangoceuticals inc-1,136,640
nanoviricides inc-1,545,840
curis inc-872,186
mainz biomed n v-868,295
ARMISTICE CAPITAL, LLC got rid off the above stocks

Sector Distribution

ARMISTICE CAPITAL, LLC has about 62.1% of it's holdings in Healthcare sector.

  • Healthcare
  • Technology
  • Others
  • Consumer Cyclical
  • Consumer Defensive
  • Communication Services
  • Industrials
Sector%
Healthcare62.1
Technology12.7
Others12.1
Consumer Cyclical6.8
Consumer Defensive2.8
Communication Services1.9
Industrials1.4

Market Cap. Distribution

ARMISTICE CAPITAL, LLC has about 33.2% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • LARGE-CAP
  • SMALL-CAP
  • UNALLOCATED
  • MEGA-CAP
  • MICRO-CAP
Category%
MID-CAP31
LARGE-CAP26.2
SMALL-CAP20.3
UNALLOCATED12.2
MEGA-CAP7
MICRO-CAP2.7

Stocks belong to which Index?

About 65.7% of the stocks held by ARMISTICE CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
  • S&P 500
Index%
RUSSELL 200045.1
Others34.2
S&P 50020.6
Top 5 Winners (%)%
MGNX
macrogenics inc
77.5 %
NKTR
nektar therapeutics
69.1 %
REED
reeds inc
68.7 %
DOW
dow hldgs inc
65.6 %
CIEN
ciena corp
58.8 %
Top 5 Winners ($)$
AGIO
agios pharmaceuticals inc
19.0 M
NKTR
nektar therapeutics
17.4 M
MGNX
macrogenics inc
7.9 M
AVNS
avanos med inc
7.2 M
alto neuroscience inc
5.7 M
Top 5 Losers (%)%
NXGL
nexgel inc
-74.5 %
MTP
biodexa pharmaceuticals plc
-71.9 %
IVDA
iveda solutions inc
-66.3 %
BEAT
heartbeam inc
-62.5 %
ARAY
accuray inc del
-50.3 %
Top 5 Losers ($)$
TVTX
travere therapeutics inc
-36.8 M
PTCT
ptc therapeutics inc
-19.1 M
RIGL
rigel pharmaceuticals inc
-16.7 M
MDGL
madrigal pharmaceuticals inc
-15.6 M
HUBS
hubspot inc
-15.5 M

ARMISTICE CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC has 251 stocks in it's portfolio. About 17.5% of the portfolio is in top 10 stocks. TVTX proved to be the most loss making stock for the portfolio. AGIO was the most profitable stock for ARMISTICE CAPITAL, LLC last quarter.

$3.03BTotal Value
459Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of ARMISTICE CAPITAL, LLC, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
AKTX
Akari Therapeutics Plc

Akari Therapeutics Plc

AKTX
ARMISTICE CAPITAL, LLC's holding in Akari Therapeutics Plc over time
0%38,922
$200.4K
0%
new position
AKTX
Akari Therapeutics Plc

Akari Therapeutics Plc

AKTX
ARMISTICE CAPITAL, LLC's holding in Akari Therapeutics Plc over time
0%0.00
$0.00
0%
decreased 100 percentsold off
ALC
Alcon Ag

Alcon Ag

ALC
ARMISTICE CAPITAL, LLC's holding in Alcon Ag over time
0%0.00
$0.00
0%
decreased 100 percentsold off